SEC Form 4 · accession 0001127602-15-007785
THERMO FISHER SCIENTIFIC INC. · TMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas W Loewald
Officer — Senior Vice President
Period of report
Feb 20, 2015
Accepted (ET)
Feb 23, 2015 · 7:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000097745
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2015 | M | 15,037 | $54.97 | A | 51,899 | D | |
| Common StockF1 | Feb 20, 2015 | S | 15,037 | $127.94 | D | 36,862 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $54.97 | Feb 20, 2015 | M | 15,037 | D | — | Feb 23, 2018 | Common Stock | 15,037 | 7,013 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.78 to $128.27, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 23, 2012, 2013, and 2014, and the last installment becomes exercisable on February 23, 2015.